Alemtuzumab and Fatal Myocarditis
Neil J Scolding1, Hiam Ali1, Mary Sheppard1
1Burden Professor of Clinical Neurosciences (NJS), University of Bristol and Southmead Hospital, Bristol, United Kingdom; Consultant Pathologist (HA), United Kingdom; Professor of Cardiovascular Pathology (MS), Department of Cardiovascular Pathology, St George's Medical School, University of London, United Kingdom; and Director of Transplant and Consultant Cardiac Surgeon (ARS), Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, Harefield, Middlesex, United Kingdom.
No abstract available in PubMed .
More Related Videos
06:49Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy
Published on: May 31, 2017
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Mitral Stenosis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
